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Structured Abstract 
Background 
Natural bioproducts are invaluable resources in drug discovery. Isoquinoline alkaloids of 
Chelidonium majus constitute a structurally diverse family of natural products that are of great 
interest, one of them being their selectivity for human telomeric G-quadruplex structure and 
telomerase inhibition. 
Methods  
The study focuses on the mechanism of telomerase inhibition by stabilization of telomeric G-
quadruplex structures by berberine, chelerythrine, chelidonine, sanguinarine and papaverine. 
Telomerase activity and mRNA levels of hTERT were estimated using quantitative telomere 
repeat amplification protocol and qPCR, in MCF-7 cells treated with different groups of alkaloids. 
The selectivity of the main isoquinoline alkaloids of Chelidonium majus towards telomeric G-
quadruplex forming sequences were explored using a sensitive modified thermal FRET-melting 
measurement in the presence of the complementary oligonucleotide CT22. We assessed and 
monitored G-quadruplex topologies using circular dichroism (CD) methods, and compared spectra 
to previously well-characterized motifs, either alone or in the presence of the alkaloids, Molecular 
modeling was performed to rationalize ligand binding to the G-quadruplex structure. 
Results  
The results highlight strong inhibitory effects of chelerythrine, sanguinarine and berberine on 
telomerase activity, most likely through substrate sequestration. These isoquinoline alkaloids 
interacted strongly with telomeric sequence G-quadruplex. In comparison, chelidonine and 
papaverine had no significant interaction with the telomeric quadruplex, while they strongly 
inhibited telomerase at transcription level of hTERT. Altogether, all of the studied alkaloids 
showed various levels and mechanisms of telomerase inhibition.  
Conclusions  
We report on a comparative study of anti-telomerase activity of the isoquinoline alkaloids of 
Chelidonium majus. Chelerythrine was most effective in inhibiting telomerase activity by substrate 
sequesteration through G-quadruplex stabilization.  
General Significance 
Understanding structural and molecular mechanisms of anti-cancer agents can help in developing 
new and more potent drugs with fewer side effects. Isoquinolines are the most biologically active 
agents from Chelidonium majus, which have shown to be telomeric G-quadruplex stabilizers and 
potent telomerase inhibitors.  
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Highlights: 
- Isoquinoline alkaloids from Chelidonium majus bind selectively to telomeric G-quadruplex and 
inhibit telomerase activity via substrate sequestration 
- Selectivity to G-quadruplex studied using a novel, sensitive modified transition-FRET (tFRET) 
assay in the presence of complimentary oligonucleotide  
- The ligands bind to the terminal quartet and maximize π-π        g              in the 3+1 hybrid 
topology quadruplex 
 
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
 
4 
1. Introduction 
Bioactive natural compounds have been explored as new agents to combat malignancies, 
overcome drug-resistance and prevent carcinogenesis [1]. Telomerase is a key target for 
therapeutic intervention in cancer cells. It has been shown to be selectively inhibited by natural 
products including berberine, sanguinarine and their derivatives via G-quadruplex (G4) 
stabilization [2,3]. The extract and derivatives from Chelidonium majus have been used in 
treatment of several malignancies including gastric and breast cancer since 1896 [4-7]. The extract 
includes several chemically and pharmacologically interesting alkaloids [8], in which the most 
biologically active components are isoquinolines and their derivatives (Figure 1) [9]. Isoquinolines 
have shown different cytotoxic mechanisms in several transformed and malignant cell types [9-
14]. For example, chelidonine and sanguinarine have shown varying apoptogenic strength without 
DNA damage [15], while some others have shown radio-protective effects on normal but not 
cancer cells [16]. Ukarin, a synthetic derivative related to these compounds, has shown selective 
inhibition of cancer cells, with no significant toxicity in normal cells even at much higher 
concentrations [17]. Of the several mechanisms, inhibition of telomerase via G4 stabilization 
remains an attractive proposition. 
 
The enzyme telomerase is over-expressed, by up to a hundred-fold, in more than 85% of cancer 
cells [18]. It rescues cancer cells from end-replication problem by maintaining telomere length 
using its intrinsic RNA as the template [19], thus conferring a strong selective advantage for 
continued growth of malignant cells [20-22]. The guanine-rich, single strand terminal ends of 
telomeres may fold into a strong and stable intramolecular G4 structures, which prevents 
accessibility to telomerase [23]. Various strategies have targeted this structure to suppress 
telomerase activity in rapidly dividing cancer cells [24-26].  
 
One approach put forward by the Neidle group is to stabilize G4 structures using small molecules; 
thereby preventing access to single stranded telomeric DNA for telomere elongation by telomerase 
[27]. Our previous screening studies on G4 stabilizing natural agents showed that isoquinoline 
alkaloids of Chelidonium majus could suppress proliferation and active telomerase content of 
cancer cells [13, 14, 28]. Various sets of isoquinolines like berberine have been studied for their 
mode of interactions with telomeric G4 DNA including their stoichiometry [29] and energetics of 
binding [30]. Molecular modeling and NMR spectroscopic data are available on berberine and 
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sanguinarine, highlighting their selectivity for G4 DNA and the dominant role aromatic moieties 
play in G4 binding [2,31]. 
 
In this study, we focused our investigation on the mechanisms of telomerase inhibition by 
stabilizing G4 DNA via berberine, chelerythrine, chelidonine, sanguinarine and papaverine. We 
explored hTERT expression level in parallel with telomerase activity in treated cells. The probable 
direct interaction of the compounds with telomerase ribonucleoprotein were studied using ligand-
TRAP experiments and the selectivity of ligand binding to telomeric G4 DNA versus ds-DNA was 
explained by classical and a novel modified thermal FRET-melting assays. Sequence dependence 
G4 topology, associated ligand preference and thermal stability to various alkaloids was also 
monitored using CD methods.  
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2. Material and methods 
2.1. Cell culture and cytotoxicity 
Human breast adenocarcinoma cell line MCF7 (ACC115 from DSMZ) were maintained in 75 cm2 
culture flasks in DMEM, supplemented with 10% heat-inactivated fetal bovine serum, 100 U/ml 
                100 μg/                (all the materials from PAA, Austria). Cells were grown in 
5% CO2 and 90% humidity at 37°C. Cell viability was evaluated routinely by trypan blue 
exclusion method using a hemocytometer.  
 
Among the commercially available different classes of isoquinoline alkaloids, 12 pure compounds 
were purchased from Sigma-Aldrich. Cytotoxicity of the compounds was estimated using MTT 
method [32]. Briefly, cells in the exponential phase (24 hours after seeding in 96 well plates 10000 
cells per well) were incubated with various concentrations of the desired compound freshly 
prepared from the stock solutions (10 or 50 mM in absolute ethanol). The final concentration of 
ethanol was always less than 0.1%. After incubation for 48 hours, MTT 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl-tetrazolium bromide (Sigma-Aldrich) was added to a final concentration of 0.5 
mg/ml to each well. The plate was further incubated for four hours for MTT reduction to formazan 
purple product through mitochondrial dehydrogenases of viable cells.  The absorbance was read at 
570 nm using a plate reader (BioTek, USA) after dissolving the formazan product in 
dimethylsulfoxide containing 10% SDS and 1% acetic acid. The tests were repeated at least 3 
times each in triplicates and the LD50 values were calculated from dose-response curves using 
Gen5 version1.06 software. 
 
2.2. Circular dichroism  
The oligonucleotide telo-G21 (5ꞌ-GGG(TTAGGG)3-3ꞌ) was purchased from Eurofins Genomics. 
The sample was first dissolved in water, then diluted to a final concentration of 0.01 mM in buffer 
consisting of KCl (100 mM) and sodium Cacodylate (10 mM, pH 7.2). The sample was heated at 
95°C in the heating block for two minutes and then left cooling overnight at room temperature and 
then stored at 4°C. The ligands, chelerythrine, papaverine, berberine and chelidonine, were 
purchased from Sigma-Aldrich, the sanguinarine was purchased from Cambridge bioscience. They 
were all dissolved in di-methyl sulfoxide (DMSO) at the final concentration of 33 mM and then 
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stock solutions of ligands at the concentrations of 0.01 mM, 0.1 mM and 1 mM were prepared 
doing several dilutions with water.  
 
Twenty solutions (final volume 0.2 ml) of complexes DNA-ligands were prepared adding DNA 
solution (final concentration 0.001 mM), in sodium Cacodylate buffer (final concentration 10 mM, 
pH 7.2 and KCl 100 mM), water to take to volume and the right amount of ligand solution to 
obtain the final concentrations of 1 mM, 0.1 mM, 0.01 mM and 0.001 mM for each ligand, and 
two more solutions of complex DNA-chelerythine were prepared at these ratios: 1:4 and 1:2. The 
solutions were incubated at 37°C for two hours, then circular dichiroism experiments were carried 
out on Chirascan Plus using quartz cells of 0.1 cm path length (scan rate 4 s/nm) at 25°C. 
 
2.3. Quantitative Telomere Repeat Amplification Protocol (q-TRAP) 
Sub-confluent MCF-7 cells were seeded in 6 well plates and incubated for 48 hours with various 
concentrations of the test compound. Cells were washed with PBS, lysed according to Kim et al. 
[33] and incubated for 30 min at 4°C. The lysates were centrifuged at 16,000×g for 30 min at 4°C. 
Protein concentration of supernatant was measured by Bradford method [34]. Q-TRAP assay was 
performed by real-time SYBR-Green method [35] with small modifications as previously reported 
[36]. The reaction mixtures including 1X SYBR Green master mix (GenetBio, South Korea), 1 µg 
protein of cell extract, 10 pmol TS (5'-AATCCGTCGAGCAGATT-3') and 5 pmol ACX (5'-
GCGCGGCTTACCCTTACCCTTACCCTAACC-3') primers were incubated for 30 min at 25°C. 
DNA products from telomerase activity were amplified using the following conditions: The hot-
start taq polymerase was activated by heating at 94°C for 10 min followed by 40 cycles of 30 sec 
at 94°C, 30 sec at 50°C and 45 sec at 72°C with signal acquisition on a real-time thermal cycler 
Rotor Gene 3000 (Corbett Research). The threshold cycle values (Ct) determined by Rotor Gene 
6.01 software were compared with the standard curve generated from serially diluted cell lysate of 
untreated MCF-7 control. Each experiment included a negative control, which was a reaction mix 
without cell extract or a heat / RNase-treated sample to inactivate telomerase. This experiment was 
performed for every test compound in at least three logically independent repeats with three or 
more samples per point. 
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For ligand-TRAP tests, the reactions were incubated with the desired concentrations of alkaloid 
before or after telomerase activity as explained above [37] with small modifications. Briefly, a 
master mix of q-TRAP reaction including MCF-7 cell lysate was prepared and aliquoted to two 
sets on ice (A and B). Various concentrations of the desired alkaloid were added to samples of set 
A and incubated for 30 minutes on ice. Then all samples of both sets were incubated for 20 min at 
24°C for extending TS primer by telomerase. All the samples were put back on ice and the same 
concentrations of alkaloid as set A was added to the samples of set B. Only Taq polymerase will 
be exposed to the alkaloids in this set. The amplification and quantification were done as described 
in the previous section. This experiment has been repeated at least three times, and each repeat 
included triplicate samples for each concentration of the alkaloid. Traces of RNase contamination 
that potentially can give rise to false positive results was checked by incubating total RNA with 
aliquots of the alkaloids for 0 or 30 min at room temperature followed by electrophoresis in 
agarose gel. 
  
2.4. Total RNA isolation, cDNA synthesis and Real-time PCR 
Total RNA was isolated from the control and treated MCF-7 cells using RNX-Plus solution 
(SinaClone BioScience, Iran)         g                    ’              . cDNA synthesis was 
             2 μg                    g MMULV                       (V           rea). 
Expression levels of the hTERT and β2      g        genes were detected by quantitative reverse 
transcription polymerase chain reaction (qRT-PCR) that used specific intron-spanning primers as 
explained above [36]. Briefly, 1 µl of each cDNA sample was subjected to PCR-amplification 
reaction including SYBR Green PCR Master Mix (GenetBio, Korea) and 5 pmol of each primer. 
Relative   N                  TE T g                              g g     β2      g         
was compared among the control and treated samples using the related standard curves calculated 
by Rotor-Gene 6.01 software.    
 
2.5. Thermal FRET and CD analysis 
The probable interaction of the alkaloids with telomerase substrate and interference with the 
enzyme activity was estimated through a simple thermal melting experiment based on Guedin et 
al., 2010 [38] with small modifications. By using these methods we can demonstrate the structural 
stabilization effect of the alkaloids on a dual-labeled fluorescence synthetic oligonucleotide of 
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9 
human telomere sequence rich in guanine, F21T (FAM 5'-GGG(TTAGGG)3-3' TAMRA) and 
native telo-21G (5'-GGG(TTAGGG)3-3'), which inherently fold to an intramolecular G4 DNA. 
Fluorescence intensity of F21T was measured while heating gradually from 30 to 98°C at the rate 
of 1°C/min while for CD from 37 to 98°C at the rate of 1min/°C. G4 DNA structures unfold at 
high temperatures.  The temperature at which the transition from folded to unfold structure occurs, 
correlates to the melting temperature (Tm).  The ligands that preferentially bind to and stabilize the 
folded state of F21T and unlabeled telo-21G increase its Tm.  
 
FRET fluorescence intensity increased in an almost two state denaturation pattern. Briefly, F21T at 
                       0.25 μM w             95°      10      immediately chilled on ice and 
incubated at 37°C for 2 h in presence of sodium cacodylate (10mM) and KCl (100 mM); and 
equimolar concentration of the desired alkaloid. Fluorescence intensity of F21T was detected using 
Rotor Gene 3000 real-time thermal cycler (Corbett Research) as the temperature was increased at 
the rate of 1°C/min. The correlated melting temperatures were calculated by using differential 
fluorescence intensity of F21T as a function of temperature with Rotor Gene software version 1.06 
and compared with that of the oligonucleotide alone. The denaturation pattern monitored by CD 
shows a single state melt unmodified by the presence of ligands (Figure 5B). For CD thermal 
experiments the materials were prepared as previously described, where the signals were collected 
after each step of increasing temperature by the rate of 1°C/min from 37 to 90°C from 220 nm to 
320 nm (scan rate 0.5 s/nm). 
 
Another set of FRET experiments, called transition FRET (t-FRET), were conducted with a 
similar protocol except that the reactions contained equimolar concentrations of the 
complementary oligonucleotide CT22 (CCCTAA)3CCCT and F21T. After initial heating to unfold 
the oligonucleotides and immediately chilling on ice, folding to duplex or quadruplex can occur 
competitively by incubating at 37°C. The duplexes will cause strong fluorescence intensity of 
F21T due to the greater distance between the dyes in duplex structure relative to quadruplex 
structure. This set of experiments may evaluate the binding specificity of the compounds to 
quadruplex structure of F21T with low fluorescence. The higher fluorescence intensity at the start 
point of FRET measurement demonstrates priority of unfolded state of F21T, which participates in 
duplex DNA with the CT22 oligonucleotide. However, in presence of ligands, lower fluorescence 
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intensity at the beginning of the FRET measurement can be explained with folded state of F21T 
into quadruplex that is stabilized with high affinity of the ligand to this structure. In such cases, the 
melting temperature is expected to be higher than control samples. 
 
2.6. Molecular Dynamics (MD) simulations 
 
The hybrid 3+1 topology of intramolecular telomeric quadruplex (PDB id 2MB3) was used as the 
starting point to study G4-ligand interactions [64]. The docking and molecular dynamics protocol 
was adapted from Ohnmacht et al. [39].  
 
The chemical structures of the ligands were sketched, built and docked using ICM-Pro software 
[40]. The charges were assigned using the ICFF force field. Grid maps were made that 
encompassed the terminal quartet. Docking was done using the automated docking module in 
ICM-Pro software, employing the default parameters. The final docked conformation was chosen 
based on the strongest binding energy between the docked ligand and the quadruplex. The docked 
complex for each ligand was chosen as the starting structure for MD simulations.  
 
The stability of ligand-G4 complexes were assessed by MD simulations. The complexes were set 
up using the xleap module in the AMBER14 molecular dynamics package [41]. The simulations 
were carried out in parmbsc1 version of Cornell et al. force field with XOL4 modifications [42-
44]. The system was solvated in a periodic box whose boundaries extended at least 10 Å from any 
solute atom. The complexes were neutralized by adding K+ ions and Amber-adapted Joung and 
Cheatham parameters specific for TIP3P waters were used [45]. 
 
The complexes were first minimised using 1000 steps of steepest descent, followed by 1000 
steps of conjugate gradient minimisation. A 300 ps of MD equilibration was run in which the 
G4 was restrained while the ions and water were allowed to equilibrate. The systems were 
gently heated from 0 K to 300 K with a time step of 0.5 ps followed by another round at 
constant pressure at 300 K for 1 ns. The constraints were gradually relaxed until no constraints 
were applied on the systems. The final production MD run was carried out for 250 ns using 
ACEMD [46]. The default parameters were used and included 10Å non-bonded cut-off, 
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0.0001Å tolerance was allowed for the SHAKE algorithm, an integration step of 2 fs, constant 
pressure of 1 ATM at 300 K temperature. The frames were collected every 20 ps and the 
analysis of the trajectory was performed using the CPPTRAJ module of AMBER. VMD was 
used to visualise the trajectories [47] and the figures were made in the ICM-Pro software.  
 
2.7. Statistical analysis  
Statistical analysis was performed by using one-way ANOVA test and a p < 0.05 was considered 
as the cut off for significant difference. 
 
3. Results 
3.1. The alkaloids showed different level of cytotoxicity in cell culture 
MTT experiments in 48 h treated MCF-7 cells with berberine, chelidonine, sanguinarine and 
chelerythrine (Figure 1) estimated LD50 values as 54, 8, 3 and 2.5 µM respectively. The cytotoxic 
effects of all of the compounds are strongly time- and dose-dependent. The rate of cell death 
increased sharply even at very low concentrations, while it reached a gradual rate around and 
beyond the LD50 (Figure 2). Papaverine was the least cytotoxic compound amongst these 
alkaloids. Its 48h LD50 has been previously reported to about 120 µM in MCF7 [48] and HepG2 
cells [49]. 
 
3.2. Isoquinoline alkaloids generally do not change the CD signature of telo-21G in 
annealed in either sodium or potassium.      
A positive peak at 251 nm and two small maxima at 271 and 288 nm were seen in the CD 
spectrum of the human telomeric sequence telo-21G (Figure 3), similar to when annealed in either 
potassium or sodium buffers (data not shown). The human telomeric sequence may adopt an anti-
parallel, parallel, or 3+1 hybrid G-quadruplex topologies. The observed CD spectrum suggests a 
mixture of G-quadruplex conformations with different proportions or an interchangeable base 
stacking within the structures [47,65]. However in presence of the ligands the signature remained 
unchanged except for a slightly stronger intensity of the maxima at 288 nm and a small decrease in 
maxima at 271 than the telo-21G alone except for chelerythrine. The strongest changes were 
observed in presence of chelerythrine followed by modest changes for berberine, chelidonine, 
sanguinarine, and papaverine. Chelerythrine at the molar ratio of 1:4 ligand:telo-21G         
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   g       12       g             2         16% decrease in minimum at 238 nm than telo-21G   
alone (Figure 3). A moderate shift about 3.8 and 5.4°C in T1/2 of telo-21G in presence of 
chelerythrine at molar ratio of 1:4 and 1:2 ligand: telo-21G was detected in thermal CD 
experiment.  
 
3.3. Telomerase activity was suppressed by alkaloids to various extents 
Quantitative telomere-repeat amplification protocol (qTRAP) measurements assessed IC50 levels 
of each compound in samples containing equal amounts of total protein (Figure 4).  A dose-
dependent inhibitory effect was seen in MCF-7 cells treated with the alkaloids. The concentration 
of the alkaloid that leads to 50% telomerase inhibition in MCF-7 cells after 48 hours incubation, 
its IC50, was estimated as 27, 1.25, 1, 1.25 and 60 µM for berberine, chelerythrine, chelidonine, 
sanguinarine and papaverine respectively. In the treated cells berberine at LD50 concentration 
(estimated using MTT assay) suppressed telomerase activity down to 10% of untreated cells. The 
LD50 concentration of chelerythrine showed 60% inhibition of telomerase in the qTRAP assay, 
although it was able to inhibit telomerase even at a very low concentration in a dose-dependent 
manner. Telomerase activity was strongly inhibited at very low concentrations of chelidonine or 
sanguinarine and progressed to almost complete inhibition at their respective LD50.  
 
 
3.4. Chelidonine decreased hTERT expression significantly 
All of the studied alkaloids showed a decreasing effect on the relative hTERT mRNA levels in 
treated MCF-7 cells (Figure 4, black lines). Berberine, inhibited hTERT transcription down to 
about 18 ± 5.2% of untreated control cells at 3 µM and with no further decrease up to its LD50 
value of 54 µM. However, chelidonine showed a significant suppression of hTERT transcription. 
The quantitative real-time RT-PCR technique estimated the strongest decrease in mRNA level of 
hTERT in MCF-7 cells 48 h treated with 8 μM                3.5 ± 1.5 % of untreated controls. A 
reduction of hTERT mRNA level to ~60% and less than 40% of untreated cells was observed 
when the cells were treated with 0.1 and 1 µM of chelidonine, respectively (Figure 4). 
Chelerythrine and sanguinarine reduced hTERT transcription to 35 ± 3.2% and 32 ± 3.3% of 
untreated controls at their respective IC50 values.  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
 
13 
 
3.5. Chelerythrine showed the strongest interaction with G4 structure  
Thermal FRET analysis of the double-labeled oligonucleotide F21T showed different Tm for G4-
alkaloid complexes, indicating that the complexes tested here had different stabilities (Figures 5 
and 6B). The Tm values of F21T in 100 mM sodium cacodylate buffer containing 100 mM KCl 
were calculated at 73°C using dF/dT curves by Rotor-Gene 6.01 software.  
 
The significant high Tm measured for F21T in presence of Chelerythrine and Sanguinarine 
indicated a strong binding with telomeric G4 structures. Chelerythrine showed the strongest 
interaction with F21T; as it increased the melting temperature by ~6 °C at equal concentration of 
F21T and chelerythrine (Figures 5A and 6B green line). Sanguinarine also showed strong binding 
to F21T, although it was weaker than chelerythrine (Figure 5A and 6B orange line). T   ΔTm 
caused by sanguinarine on F21T was about 3°C at equimolar concentration. However, berberine, 
cheldionine and papaverine did not increase the melting temperature of F21T at 1:1 concentration 
ratio (Figures 5A and 6B; the dark blue, red and blue curves respectively). This suggests a very 
weak interaction between these alkaloids and F21T. The interaction of the ligands with the 
unlabeled telo-21G and its stabilization as monitored by CD290 nm melting shows a similar overall 
pattern from strong binding to weaker interactions (Figure 6A; the same colors as 5A and 6B). 
 g                     w           g                        g   ΔTm of 18°C at 100/1 with 
berberine second at 12°C, both cheldionine and papaverine were the weakest.  
 
3.5.1. G4-duplex transition in the presence of ligands  
The specificity of interactions of alkaloids with G-rich F21T oligonucleotide was verified by 
performing G4-duplex transition experiments in the presence of the complementary 
oligonucleotide CT22 using a modified thermal FRET method. In these experiments, equimolar 
solutions of both, F21T and CT22, were first boiled at 95°C for 10 min followed by immediate 
chilling on ice. Incubating the mixture of oligonucleotides at 37°C allows folding of either duplex 
or quadruplex structures. A duplex structure will be preferred in the absence of a quadruplex 
stabilizing ligand. Formation of the folded structure in G-rich strand will be detectable by lower 
fluorescence intensity than control at the beginning of heating step in FRET measurements. In the 
absence of any alkaloid, an equimolar mixture of F21T and CT22 showed a sigmoidal curve 
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starting with high fluorescence intensity at the beginning of FRET measurements (because of 
flurophore dye separation by duplex formation) followed by a clear transition step,           “a” 
(Figure 5A, middle), that correlated with melting temperature of the double helix structure. 
However, when the strands are separated (at least a fraction of) the G-rich strand F21T 
   g                          G4           (           “GQ” in the curve). By continued heating, a 
second transition step occurs by denaturing the quadruplexes and if any suitable ligand stabilizes 
     G4              ∆Tm will be observed,          “b”        curve (Figure 5B, middle). 
 
Folding of F21T in the presence of any ligand will lead to fluorescence quenching. On the other 
hand, if the ligand strongly interacts with the duplex and stabilizes it, no such quenching will occur 
and probably a positive ∆Tm is recorded                    “ ”. Meanwhile the ligands that interact 
with G4 structure may quench fluorescence leading to lower fluorescence intensity, G4 formation 
   F21T      w                       g      ∆Tm                    “ ”. This modified FRET-
melting method may help to differentiate between quadruplex and duplex specific ligand binding. 
None of the alkaloids in this study stabilized F21T:CT22 duplex, however chelerythrine and 
sanguinarine exhibited strong fluorescence quenching at the beginning of the heating and a 
  g      ∆Tm                        “ ” (Figure 5A, middle). While other ligands made no changes 
on both transition steps. Chelerythrine and in a lesser amount sanguinarine increased Tm of F21T 
as observed in                 “ ”. This suggests the stronger effects of these two 
benzophenanthridine alkaloids on telomeric G4 stabilization. 
 
Chelidonine did not show any considerable changes in melting temperature of F21T, in presence 
or absence of CT22, although it has previously been shown to inhibit telomerase [12]. 
Chelerythrine and sanguinarine exhibited a significant stabilization effect on telomeric G4 
structure even in the presence of the complementary strand, CT22. In the presence of equimolar 
concentration of these alkaloids, the fluorescence intensity of F21T largely decreased at the 
beginning of the heating step of the FRET measurements. The lower fluorescence intensity 
reasonably correlated with the folded state of F21T quadruplex. Both chelerythrine and 
sanguinarine strongly favored F21T folding into G4 than hybridizing with CT22 to a duplex DNA. 
The lowest fluorescence intensity of F21T was detected in the presence of equimolar concentration 
of chelerythrine and sanguinarine which caused a ~50 and 40% decrease in fluorescence intensity 
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respectively. Berberine exhibited a weaker quadruplex stabilizing effect than chelerythrine and 
sanguinarine, while reducing the fluorescence intensity of F21T by about 30%. Papaverine and 
cheldionine            w       g         ΔTm in F21T similar to the classic FRET-melting 
experiments. 
 
The second transition step “ ” was almost the same as observed in classical FRET-melting 
experiments (without the complementary CT22) and the Tm values are almost the same (it was 
highlighted with red rectangle for berberine in Figure 5B). In summary these observations support 
the more selective interaction of chelerythrine than sanguinarine and berberine with telomeric 
sequences. 
 
3.5.2. Molecular dynamics of telomeric-G4 in complex with isoquinolines 
Since no structural data of the studied complexes is available, automated ligand docking and MD 
simulations were carried out to examine the plausible binding features of the ligands with the G4. 
The binding energies in kcal/mol, calculated after docking the ligands to the quadruplex were in 
the following order:  
 
Chelerythrine (-29.5) > Berberine (-25.6) > Sanguinarine (-23.6) > Chelidonine (-19.6) > 
Papaverine (-16.6) 
 
The final configuration of the systems, after 250 ns MD run revealed that the ligands stacked on 
the quartet with the chromophore maximizing the π-π stacking interactions. The nitrogen in the 
ligand molecules exhibited a preference to position on top of central electronegative channel that 
runs through the G4 (Figure 7). The final results from the MD simulations of the complexes are 
presented in the Supplementary data section. 
 
3.6. The alkaloids generally inhibited both telomerase and Taq polymerase 
Ligand-TRAP assay carried out in the presence of chelerythrine, berberine and sanguinarine 
showed that the alkaloids inhibited telomerase by varying degrees (Figure 8). The effect was not 
specific to telomerase as similar effect was observed when the alkaloids were added after telomere 
elongation, in which only the Taq polymerase was active. Thus both telomerase and Taq 
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polymerase were inhibited by chelerythrine, sanguinarine and berberine. It suggests that strong 
interaction of these alkaloids with G-rich telomeric sequences, as seen in thermal FRET 
experiments, is most likely by interfering with both telomerase and Taq activity. Telomerase 
inhibition appears after a few rounds of primer extension activity of the enzyme by adding the 
TTAGGG repeats, which adopts G4 structure. The strong interaction of alkaloids may restrict 
access to the substrate. However in presence of chelerythrine, telomerase was more inhibited than 
taq polymerase, as incubation with chelerythrine before substrate extension by telomerase showed 
less TRAP products than incubation after that (Figure 8). No significant reduction in activity of 
telomerase and/or Taq polymerase was observed in our ligand-TRAP experiments when incubated 
with chelidonine (data not shown).  
 
4. Discussion 
Discovery of new drugs that are selectively cytotoxic against cancer cells is one of the primary 
objectives for effective cancer treatment. Natural alkaloids of Chelidonium majus, have been 
reported to induce various cell death mechanisms especially through apoptosis induction [15]. The 
most important benzylisoquinolines in this plant include chelidonine, sangunarine, chelerythrine, 
and berberine with slightly different structures and various extents of anti-proliferative effects in 
cancer cell lines [51-54]. However, more investigation is required to elucidate the detailed 
mechanisms and structure-function relationship relevant to their antiproliferative effects.  
 
This study has focused on a comparative study of selective binding to G4 DNA and anti-
telomerase activity of the main alkaloids of C. majus. MTT experiments revealed that all the 
compounds were cytotoxic in MCF-7 cells. Chelerythrine and sanguinarine were the most 
cytotoxic alkaloids, while chelidonine having a hydroxyl group exhibited a relatively less 
cytotoxicity. Papaverine, a benzyl-isoquinoline alkaloid with fewer aromatic rings in its structure 
and more flexible than berberine, has shown least cytotoxicity (LD50 about 120 µM estimated 
using MTT). Papaverine also has inhibitory effects on telomerase activity and hTERT expression 
in both MCF-7 [48] and HepG2 [49]. 
 
Detection of telomerase activity using a Quantitative TRAP assay revealed a very low-level of 
telomerase activity in MCF-7 cells treated with chelidonine or sanguinarine. As this assay 
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measured the enzyme activity in equal amounts of total protein in samples, the reduced activity 
implies depletion of the relative amount of the active ribonucleoprotein. Telomerase regulation 
albeit very complicated, is mainly through transcriptional regulation of the catalytic subunit of the 
enzyme [53]. In the treated MCF-7 cells with chelidonine and sanguinarine, hTERT mRNA levels 
followed the same diminution as the telomerase activity. Sub-micromolar concentrations of both 
chelidonine and sanguinarine led to a significant decrease in telomerase activity along with a 
decrease in hTERT transcription level. Chelerythrine inhibited telomerase by most extent to ~57% 
of un-treated control cells at its LD50 (2.5 µM). Remarkably, berberine showed a significant 
decrease in telomerase activity to ~16% of untreated cells at 3 µM concentration. It is noteworthy 
that, in spite of berberine, which is a potent genotoxin and strong DNA intercalator [54-56], no 
genotoxicity and hepatotoxicity of chelerythrine and sanguinarine has been suggested in animal 
model up to 5 mg per 1 kg body weight [2, 57].  
 
Another possible mechanism of telomerase inhibition by small molecules is substrate sequestering 
through G4 stabilization [58, 59]. Our thermal FRET analysis suggests chelerythrine exhibited 
greatest affinity and specificity among the studied benzophenantridines towards telomeric G4 
DNA (Figure 5). It interacted strongly with the synthetic substrate of telomerase and stabilized the 
folded G4 structure making it inaccessible to the enzyme. G4 structure stabilization was recorded 
for sanguinarine in a considerably stronger extent than berberine. The ∆Tm of F21T varied 
considerably in presence of these three alkaloids, although molecular modeling methods suggest 
almost the similar mode of interactions and comparable binding energies in the hybrid 3+1 
topology [64]. Non-electrostatic interactions in the binding of small molecules to G4 are preferable 
for telomerase inhibition under physiological conditions [60]. Amongst the alkaloids tested here, 
chelidonine is estimated to have less non-electrostatic interactions than the others as it has an extra 
hydroxyl group and lesser number of aromatic rings. As thermal FRET analysis did not detect any 
considerable increase in melting temperature of F21T in presence of chelidonine, direct 
interference with the telomerase activity by substrate sequestration may not contribute to the 
inhibition mechanism. In our ligand-TRAP analysis also, no significant change in telomerase 
and/or Taq polymerase activity was seen after various incubation times with chelidonine. This is 
consistent with other reports indicating only a minor DNA binding capacity for chelidonine [51]. 
In conclusion, chelidonine does not interact with telomerase (after ligand-TRAP data) nor does it 
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sequester its substrate (after thermal FRET data), but strongly inhibited telomerase mainly through 
hTERT suppression (after qPCR measurments of the hTERT mRNA). Similarly and in agreement 
with our previous reports [28, 49], papaverine also showed no significant interaction with 
telomeric quadruplex.  
 
CD experiments confirm the hybrid 3+1 topology of the G4 structures in presence of the studied 
alkaloids. The ligands showed no considerable changes to enhance the 260 nm peak, while 
reduced the negative peak at 234 nm. This implies almost a similar mode of interaction of the 
ligands with F21T and the unlabeled telo-21G.  
 
In conclusion, chelerythrine, sanguinarine and berberine, interfered with telomerase activity by 
limiting substrate accessibility; while down-regulation of the hTERT gene may also have an 
important contribution [61]. It is known that several G-rich regions exist in promoter of hTERT 
[62]. Whether the latter effect is a consequence of G4 interaction with these isoquinolines requires 
further investigation. These regions are expected to be additional targets for G4 formation in the 
presence of chelerythrine, sanguinarine and berberine.  
 
Based on thermal FRET observations, the number of fused aromatic rings of the ligands may have 
the highest impact on the strength of interaction with telomeric quadruplex. So that by reducing 
the number of the aromatic rings or separating them a smaller ∆Tm will be expected. Inclusion of 
polar substitutions may decrease the interaction. The benzophenanthridine alkaloids have stronger 
interaction with telomeric G4 structure than other isoquinolines. Also, opening the methylene 
dioxy rings may enhance the interactions. This highlights the priority of aromatic and hydrophobic 
interactions in binding of these ligands to telomeric G-quadruplex. 
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Figure Legends 
Figure 1: Chemical structures of berberine, chelidonine, chelerythrine, sanguinarine, and 
papaverine. 
Figure 2: Cell viability of MCF7 cells after 24 (light gray), 48 (gray) and 72 (black) hours 
treatment with different concentrations of berberine, chelerythrine, chelidonine and sanguinarine 
as estimated by MTT. Mean values ± standard error of means is shown. 
 
Figure 3: CD spectra of telo-21G    1 μM                  10  M sodium cacodylate buffer and 
100 mM KCl pH 7.2 alone (purple) and in the presence of an increasing ligand concentration of 
chelerythrine, sanguinarine, berberine, chelidonine and papaverine represented by green, black, 
red, blue, yellow curves respectively at ratios 1:1 (A), 10:1 (B), 100:1 (C) (ligand/ telo-21G. (D) 
Chelerythrine in the presence of telo-21G    0.25     0.5 μM  (2:1  4:1)      g   g               
green lines respectively. 
 
Figure 4: Telomerase activity (grey line) and hTERT mRNA level (black line) estimated using q-
TRAP and real-time PCR in MCF-7 cells after 48h treatment with the alkaloids. The mean value ± 
SEM of four logical repeats, each including at least three samples for different concentrations has 
been presented. 
 
Figure 5A: Top: Classical thermal FRET analysis of F21T in 10mM sodium cacodylate, pH 7.2 
and 100 mM K+ alone (black) or equimolar concentration of Berberine (dark blue), Chelidonine 
(red), Chelerythrine (green), Papaverine (blue) and Sanguinarine (orange). Middle: t-FRET 
melting measurements of F21T in the same buffer mentioned above and presence of equimolar 
concerntation of the complementary oligonucleotide CT22. Its shows two tandem sigmoid curves 
starting with high fluorescence intensity at the beginning of FRET measurements where 
F21T:CT22 may form double stranded duplex DNA followed by a clear transition step, marked as 
“ ”.             g             F21T will be released and may fold into G4 structure (GQ). By 
continuing heating, a second transition step occurs due to denaturation of the quadruplexes, 
          “ ”            G-rich strand is also completely unfolded. Bottom: tFRET melting 
measurements of F21T in 10mM sodium cacodylate, pH 7.2 and 100 mM KCl in presence of 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
 
27 
equimolar concentration of the complementary oligonucleotide CT22 and 1:1 concentration ratio 
of alkaloids as above. Note the similar pattern of this second sigmoidal (boxed rectangle) with the 
classic FRET melting curve illustrated above.  
Figure 5B: (Left) Classical FRET melting of 0.25 μM F21T (     )    10 M sodium cacodylate, 
pH 7.2 and 100 mM KCl alone (blue) or in presence of 1:1 (red) , 10:1 (green) and 100:1 (purple) 
ratios of berberine, chelerythrine, chelidonine, papaverine and sanguinarine. (Middle) Transition 
F ET ( F ET)       g              q                         F21T      T22 (0.25 μM     )    
10 mM and 100mM sodium cacodylate without any alkaloid (black) or in presence of 1:1 (red) , 
10:1 (green) and 100:1 (violet) ratios of berberine, chelerythrine, chelidonine, papaverine and 
sanguinarine. (Right) Classical thermal CD290 nm melt analysis of telo-21G    1 μM    10 mM 
sodium                100  M                                            0  1  10      100 μM 
ligands (0:1, 1:1,10:1, 100:1 ligand/ telo-21G) in blue, red, green, purple lines respectively.   
 
Figure 6: (A) The difference in T1/2 of telo-21G in CD290 nm melting test and (B) F21T in classical 
FRET melting in sodium cacodylate buffer, pH 7.2 and 100 mM KCl and in presence of increasing 
concentrations of alkaloids.  
 
Figure 7: Conformations of the alkaloids when bound to 3+1 hybrid topology G4 DNA [64]. The 
central nitrogen in Chelerythrine (green), berberine (yellow), chelidonine (black), sanguinarine 
(red) and papaverine (blue) orients on top of the electronegative channel in the quadruplex 
structure. The side view of how all ligands bind is illustrated in the bottom right corner. 
 
Figure 8: Ligand-TRAP measurements. A master mix of q-TRAP reaction including MCF-7 cell 
lysate was prepared and aliquoted to two sets on ice. Various concentrations of the desired alkaloid 
berberine, chelerythrine and sanguinarine were added as explained in part 2.3. Treatments in 1, 3 
and 5 have been done before primer elongation by telomerase and in 2, 4 and 6 before q-PCR. In 
samples 1, 3 and 5 both telomerase and hot-start Taq polymerase have been exposed to the 
alkaloids while in samples 2, 4 and 6 only hot-start Taq enzyme has been exposed to the alkaloids. 
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Structured Abstract 
Background 
Natural bioproducts are invaluable resources in drug discovery. Isoquinoline alkaloids of 
Chelidonium majus constitute a structurally diverse family of natural products that are of great 
interest, one of them being their selectivity for human telomeric G-quadruplex structure and 
telomerase inhibition. 
Methods  
The study focuses on the mechanism of telomerase inhibition by stabilization of telomeric G-
quadruplex structures by berberine, chelerythrine, chelidonine, sanguinarine and papaverine. 
Telomerase activity and mRNA levels of hTERT were estimated using quantitative telomere 
repeat amplification protocol and qPCR, in MCF-7 cells treated with different groups of alkaloids. 
The selectivity of the main isoquinoline alkaloids of Chelidonium majus towards telomeric G-
quadruplex forming sequences were explored using a sensitive modified thermal FRET-melting 
measurement in the presence of the complementary oligonucleotide CT22. We assessed and 
monitored G-quadruplex topologies using circular dichroism (CD) methods, and compared spectra 
to previously well-characterized motifs, either alone or in the presence of the alkaloids, Molecular 
modeling was performed to rationalize ligand binding to the G-quadruplex structure. 
Results  
The results highlight strong inhibitory effects of chelerythrine, sanguinarine and berberine on 
telomerase activity, most likely through substrate sequestration. These isoquinoline alkaloids 
interacted strongly with telomeric sequence G-quadruplex. In comparison, chelidonine and 
papaverine had no significant interaction with the telomeric quadruplex, while they strongly 
inhibited telomerase at transcription level of hTERT. Altogether, all of the studied alkaloids 
showed various levels and mechanisms of telomerase inhibition.  
Conclusions  
We report on a comparative study of anti-telomerase activity of the isoquinoline alkaloids of 
Chelidonium majus. Chelerythrine was most effective in inhibiting telomerase activity by substrate 
sequesteration through G-quadruplex stabilization.  
General Significance 
Understanding structural and molecular mechanisms of anti-cancer agents can help in developing 
new and more potent drugs with fewer side effects. Isoquinolines are the most biologically active 
agents from Chelidonium majus, which have shown to be telomeric G-quadruplex stabilizers and 
potent telomerase inhibitors.  
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Keywords: chelerythrine, sanguinarine, berberine, chelidonine, papaverine telomerase, t-FRET, 
transition, G-quadruplex  
 
Highlights: 
- Isoquinoline alkaloids from Chelidonium majus bind selectively to telomeric G-quadruplex and 
inhibit telomerase activity via substrate sequestration 
- Selectivity to G-quadruplex studied using a novel, sensitive modified transition-FRET (tFRET) 
assay in the presence of complimentary oligonucleotide  
- The ligands bind to the terminal quartet and maximize π-π   a    g interactions in the 3+1 hybrid 
topology quadruplex 
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1. Introduction 
Bioactive natural compounds have been explored as new agents to combat malignancies, 
overcome drug-resistance and prevent carcinogenesis [1]. Telomerase is a key target for 
therapeutic intervention in cancer cells. It has been shown to be selectively inhibited by natural 
products including berberine, sanguinarine and their derivatives via G-quadruplex (G4) 
stabilization [2,3]. The extract and derivatives from Chelidonium majus have been used in 
treatment of several malignancies including gastric and breast cancer since 1896 [4-7]. The extract 
includes several chemically and pharmacologically interesting alkaloids [8], in which the most 
biologically active components are isoquinolines and their derivatives (Figure 1) [9]. Isoquinolines 
have shown different cytotoxic mechanisms in several transformed and malignant cell types [9-
14]. For example, chelidonine and sanguinarine have shown varying apoptogenic strength without 
DNA damage [15], while some others have shown radio-protective effects on normal but not 
cancer cells [16]. Ukarin, a synthetic derivative related to these compounds, has shown selective 
inhibition of cancer cells, with no significant toxicity in normal cells even at much higher 
concentrations [17]. Of the several mechanisms, inhibition of telomerase via G4 stabilization 
remains an attractive proposition. 
 
The enzyme telomerase is over-expressed, by up to a hundred-fold, in more than 85% of cancer 
cells [18]. It rescues cancer cells from end-replication problem by maintaining telomere length 
using its intrinsic RNA as the template [19], thus conferring a strong selective advantage for 
continued growth of malignant cells [20-22]. The guanine-rich, single strand terminal ends of 
telomeres may fold into a strong and stable intramolecular G4 structures, which prevents 
accessibility to telomerase [23]. Various strategies have targeted this structure to suppress 
telomerase activity in rapidly dividing cancer cells [24-26].  
 
One approach put forward by the Neidle group is to stabilize G4 structures using small molecules; 
thereby preventing access to single stranded telomeric DNA for telomere elongation by telomerase 
[27]. Our previous screening studies on G4 stabilizing natural agents showed that isoquinoline 
alkaloids of Chelidonium majus could suppress proliferation and active telomerase content of 
cancer cells [13, 14, 28]. Various sets of isoquinolines like berberine have been studied for their 
mode of interactions with telomeric G4 DNA including their stoichiometry [29] and energetics of 
binding [30]. Molecular modeling and NMR spectroscopic data are available on berberine and 
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sanguinarine, highlighting their selectivity for G4 DNA and the dominant role aromatic moieties 
play in G4 binding [2,31]. 
 
In this study, we focused our investigation on the mechanisms of telomerase inhibition by 
stabilizing G4 DNA via berberine, chelerythrine, chelidonine, sanguinarine and papaverine. We 
explored hTERT expression level in parallel with telomerase activity in treated cells. The probable 
direct interaction of the compounds with telomerase ribonucleoprotein were studied using ligand-
TRAP experiments and the selectivity of ligand binding to telomeric G4 DNA versus ds-DNA was 
explained by classical and a novel modified thermal FRET-melting assays. Sequence dependence 
G4 topology, associated ligand preference and thermal stability to various alkaloids was also 
monitored using CD methods.  
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2. Material and methods 
2.1. Cell culture and cytotoxicity 
Human breast adenocarcinoma cell line MCF7 (ACC115 from DSMZ) were maintained in 75 cm2 
culture flasks in DMEM, supplemented with 10% heat-inactivated fetal bovine serum, 100 U/ml 
            a d 100 μg/m         my    (all the materials from PAA, Austria). Cells were grown in 
5% CO2 and 90% humidity at 37°C. Cell viability was evaluated routinely by trypan blue 
exclusion method using a hemocytometer.  
 
Among the commercially available different classes of isoquinoline alkaloids, 12 pure compounds 
were purchased from Sigma-Aldrich. Cytotoxicity of the compounds was estimated using MTT 
method [32]. Briefly, cells in the exponential phase (24 hours after seeding in 96 well plates 10000 
cells per well) were incubated with various concentrations of the desired compound freshly 
prepared from the stock solutions (10 or 50 mM in absolute ethanol). The final concentration of 
ethanol was always less than 0.1%. After incubation for 48 hours, MTT 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl-tetrazolium bromide (Sigma-Aldrich) was added to a final concentration of 0.5 
mg/ml to each well. The plate was further incubated for four hours for MTT reduction to formazan 
purple product through mitochondrial dehydrogenases of viable cells.  The absorbance was read at 
570 nm using a plate reader (BioTek, USA) after dissolving the formazan product in 
dimethylsulfoxide containing 10% SDS and 1% acetic acid. The tests were repeated at least 3 
times each in triplicates and the LD50 values were calculated from dose-response curves using 
Gen5 version1.06 software. 
 
2.2. Circular dichroism  
The oligonucleotide telo-G21 (5ꞌ-GGG(TTAGGG)3-3ꞌ) was purchased from Eurofins Genomics. 
The sample was first dissolved in water, then diluted to a final concentration of 0.01 mM in buffer 
consisting of KCl (100 mM) and sodium Cacodylate (10 mM, pH 7.2). The sample was heated at 
95°C in the heating block for two minutes and then left cooling overnight at room temperature and 
then stored at 4°C. The ligands, chelerythrine, papaverine, berberine and chelidonine, were 
purchased from Sigma-Aldrich, the sanguinarine was purchased from Cambridge bioscience. They 
were all dissolved in di-methyl sulfoxide (DMSO) at the final concentration of 33 mM and then 
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7 
stock solutions of ligands at the concentrations of 0.01 mM, 0.1 mM and 1 mM were prepared 
doing several dilutions with water.  
 
Twenty solutions (final volume 0.2 ml) of complexes DNA-ligands were prepared adding DNA 
solution (final concentration 0.001 mM), in sodium Cacodylate buffer (final concentration 10 mM, 
pH 7.2 and KCl 100 mM), water to take to volume and the right amount of ligand solution to 
obtain the final concentrations of 1 mM, 0.1 mM, 0.01 mM and 0.001 mM for each ligand, and 
two more solutions of complex DNA-chelerythine were prepared at these ratios: 1:4 and 1:2. The 
solutions were incubated at 37°C for two hours, then circular dichiroism experiments were carried 
out on Chirascan Plus using quartz cells of 0.1 cm path length (scan rate 4 s/nm) at 25°C. 
 
2.3. Quantitative Telomere Repeat Amplification Protocol (q-TRAP) 
Sub-confluent MCF-7 cells were seeded in 6 well plates and incubated for 48 hours with various 
concentrations of the test compound. Cells were washed with PBS, lysed according to Kim et al. 
[33] and incubated for 30 min at 4°C. The lysates were centrifuged at 16,000×g for 30 min at 4°C. 
Protein concentration of supernatant was measured by Bradford method [34]. Q-TRAP assay was 
performed by real-time SYBR-Green method [35] with small modifications as previously reported 
[36]. The reaction mixtures including 1X SYBR Green master mix (GenetBio, South Korea), 1 µg 
protein of cell extract, 10 pmol TS (5'-AATCCGTCGAGCAGATT-3') and 5 pmol ACX (5'-
GCGCGGCTTACCCTTACCCTTACCCTAACC-3') primers were incubated for 30 min at 25°C. 
DNA products from telomerase activity were amplified using the following conditions: The hot-
start taq polymerase was activated by heating at 94°C for 10 min followed by 40 cycles of 30 sec 
at 94°C, 30 sec at 50°C and 45 sec at 72°C with signal acquisition on a real-time thermal cycler 
Rotor Gene 3000 (Corbett Research). The threshold cycle values (Ct) determined by Rotor Gene 
6.01 software were compared with the standard curve generated from serially diluted cell lysate of 
untreated MCF-7 control. Each experiment included a negative control, which was a reaction mix 
without cell extract or a heat / RNase-treated sample to inactivate telomerase. This experiment was 
performed for every test compound in at least three logically independent repeats with three or 
more samples per point. 
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8 
For ligand-TRAP tests, the reactions were incubated with the desired concentrations of alkaloid 
before or after telomerase activity as explained above [37] with small modifications. Briefly, a 
master mix of q-TRAP reaction including MCF-7 cell lysate was prepared and aliquoted to two 
sets on ice (A and B). Various concentrations of the desired alkaloid were added to samples of set 
A and incubated for 30 minutes on ice. Then all samples of both sets were incubated for 20 min at 
24°C for extending TS primer by telomerase. All the samples were put back on ice and the same 
concentrations of alkaloid as set A was added to the samples of set B. Only Taq polymerase will 
be exposed to the alkaloids in this set. The amplification and quantification were done as described 
in the previous section. This experiment has been repeated at least three times, and each repeat 
included triplicate samples for each concentration of the alkaloid. Traces of RNase contamination 
that potentially can give rise to false positive results was checked by incubating total RNA with 
aliquots of the alkaloids for 0 or 30 min at room temperature followed by electrophoresis in 
agarose gel. 
  
2.4. Total RNA isolation, cDNA synthesis and Real-time PCR 
Total RNA was isolated from the control and treated MCF-7 cells using RNX-Plus solution 
(SinaClone BioScience, Iran) a    d  g        ma   a      ’              . cDNA synthesis was 
      m d    2 μg     a    am        g MMULV           a       a   (V  a        rea). 
Expression levels of the hTERT and β2 m    g        genes were detected by quantitative reverse 
transcription polymerase chain reaction (qRT-PCR) that used specific intron-spanning primers as 
explained above [36]. Briefly, 1 µl of each cDNA sample was subjected to PCR-amplification 
reaction including SYBR Green PCR Master Mix (GenetBio, Korea) and 5 pmol of each primer. 
Relative m NA    y   m        TE T g         a                    g g     β2 m    g         
was compared among the control and treated samples using the related standard curves calculated 
by Rotor-Gene 6.01 software.    
 
2.5. Thermal FRET and CD analysis 
The probable interaction of the alkaloids with telomerase substrate and interference with the 
enzyme activity was estimated through a simple thermal melting experiment based on Guedin et 
al., 2010 [38] with small modifications. By using these methods we can demonstrate the structural 
stabilization effect of the alkaloids on a dual-labeled fluorescence synthetic oligonucleotide of 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
 
9 
human telomere sequence rich in guanine, F21T (FAM 5'-GGG(TTAGGG)3-3' TAMRA) and 
native telo-21G (5'-GGG(TTAGGG)3-3'), which inherently fold to an intramolecular G4 DNA. 
Fluorescence intensity of F21T was measured while heating gradually from 30 to 98°C at the rate 
of 1°C/min while for CD from 37 to 98°C at the rate of 1min/°C. G4 DNA structures unfold at 
high temperatures.  The temperature at which the transition from folded to unfold structure occurs, 
correlates to the melting temperature (Tm).  The ligands that preferentially bind to and stabilize the 
folded state of F21T and unlabeled telo-21G increase its Tm.  
 
FRET fluorescence intensity increased in an almost two state denaturation pattern. Briefly, F21T at 
   a          a        0.25 μM wa    a  d a  95°      10 m    immediately chilled on ice and 
incubated at 37°C for 2 h in presence of sodium cacodylate (10mM) and KCl (100 mM); and 
equimolar concentration of the desired alkaloid. Fluorescence intensity of F21T was detected using 
Rotor Gene 3000 real-time thermal cycler (Corbett Research) as the temperature was increased at 
the rate of 1°C/min. The correlated melting temperatures were calculated by using differential 
fluorescence intensity of F21T as a function of temperature with Rotor Gene software version 1.06 
and compared with that of the oligonucleotide alone. The denaturation pattern monitored by CD 
shows a single state melt unmodified by the presence of ligands (Figure 5B). For CD thermal 
experiments the materials were prepared as previously described, where the signals were collected 
after each step of increasing temperature by the rate of 1°C/min from 37 to 90°C from 220 nm to 
320 nm (scan rate 0.5 s/nm). 
 
Another set of FRET experiments, called transition FRET (t-FRET), were conducted with a 
similar protocol except that the reactions contained equimolar concentrations of the 
complementary oligonucleotide CT22 (CCCTAA)3CCCT and F21T. After initial heating to unfold 
the oligonucleotides and immediately chilling on ice, folding to duplex or quadruplex can occur 
competitively by incubating at 37°C. The duplexes will cause strong fluorescence intensity of 
F21T due to the greater distance between the dyes in duplex structure relative to quadruplex 
structure. This set of experiments may evaluate the binding specificity of the compounds to 
quadruplex structure of F21T with low fluorescence. The higher fluorescence intensity at the start 
point of FRET measurement demonstrates priority of unfolded state of F21T, which participates in 
duplex DNA with the CT22 oligonucleotide. However, in presence of ligands, lower fluorescence 
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10 
intensity at the beginning of the FRET measurement can be explained with folded state of F21T 
into quadruplex that is stabilized with high affinity of the ligand to this structure. In such cases, the 
melting temperature is expected to be higher than control samples. 
 
2.6. Molecular Dynamics (MD) simulations 
 
The hybrid 3+1 topology of intramolecular telomeric quadruplex (PDB id 2MB3) was used as the 
starting point to study G4-ligand interactions [64]. The docking and molecular dynamics protocol 
was adapted from Ohnmacht et al. [39].  
 
The chemical structures of the ligands were sketched, built and docked using ICM-Pro software 
[40]. The charges were assigned using the ICFF force field. Grid maps were made that 
encompassed the terminal quartet. Docking was done using the automated docking module in 
ICM-Pro software, employing the default parameters. The final docked conformation was chosen 
based on the strongest binding energy between the docked ligand and the quadruplex. The docked 
complex for each ligand was chosen as the starting structure for MD simulations.  
 
The stability of ligand-G4 complexes were assessed by MD simulations. The complexes were set 
up using the xleap module in the AMBER14 molecular dynamics package [41]. The simulations 
were carried out in parmbsc1 version of Cornell et al. force field with XOL4 modifications [42-
44]. The system was solvated in a periodic box whose boundaries extended at least 10 Å from any 
solute atom. The complexes were neutralized by adding K+ ions and Amber-adapted Joung and 
Cheatham parameters specific for TIP3P waters were used [45]. 
 
The complexes were first minimised using 1000 steps of steepest descent, followed by 1000 
steps of conjugate gradient minimisation. A 300 ps of MD equilibration was run in which the 
G4 was restrained while the ions and water were allowed to equilibrate. The systems were 
gently heated from 0 K to 300 K with a time step of 0.5 ps followed by another round at 
constant pressure at 300 K for 1 ns. The constraints were gradually relaxed until no constraints 
were applied on the systems. The final production MD run was carried out for 250 ns using 
ACEMD [46]. The default parameters were used and included 10Å non-bonded cut-off, 
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11 
0.0001Å tolerance was allowed for the SHAKE algorithm, an integration step of 2 fs, constant 
pressure of 1 ATM at 300 K temperature. The frames were collected every 20 ps and the 
analysis of the trajectory was performed using the CPPTRAJ module of AMBER. VMD was 
used to visualise the trajectories [47] and the figures were made in the ICM-Pro software.  
 
2.7. Statistical analysis  
Statistical analysis was performed by using one-way ANOVA test and a p < 0.05 was considered 
as the cut off for significant difference. 
 
3. Results 
3.1. The alkaloids showed different level of cytotoxicity in cell culture 
MTT experiments in 48 h treated MCF-7 cells with berberine, chelidonine, sanguinarine and 
chelerythrine (Figure 1) estimated LD50 values as 54, 8, 3 and 2.5 µM respectively. The cytotoxic 
effects of all of the compounds are strongly time- and dose-dependent. The rate of cell death 
increased sharply even at very low concentrations, while it reached a gradual rate around and 
beyond the LD50 (Figure 2). Papaverine was the least cytotoxic compound amongst these 
alkaloids. Its 48h LD50 has been previously reported to about 120 µM in MCF7 [48] and HepG2 
cells [49]. 
 
3.2. Isoquinoline alkaloids generally do not change the CD signature of telo-21G in 
annealed in either sodium or potassium.      
A positive peak at 251 nm and two small maxima at 271 and 288 nm were seen in the CD 
spectrum of the human telomeric sequence telo-21G (Figure 3), similar to when annealed in either 
potassium or sodium buffers (data not shown). The human telomeric sequence may adopt an anti-
parallel, parallel, or 3+1 hybrid G-quadruplex topologies. The observed CD spectrum suggests a 
mixture of G-quadruplex conformations with different proportions or an interchangeable base 
stacking within the structures [47,65]. However in presence of the ligands the signature remained 
unchanged except for a slightly stronger intensity of the maxima at 288 nm and a small decrease in 
maxima at 271 than the telo-21G alone except for chelerythrine. The strongest changes were 
observed in presence of chelerythrine followed by modest changes for berberine, chelidonine, 
sanguinarine, and papaverine. Chelerythrine at the molar ratio of 1:4 ligand:telo-21G mad  a  
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 a g  a    12       g   ma  ma a  2   a d   16% decrease in minimum at 238 nm than telo-21G   
alone (Figure 3). A moderate shift about 3.8 and 5.4°C in T1/2 of telo-21G in presence of 
chelerythrine at molar ratio of 1:4 and 1:2 ligand: telo-21G was detected in thermal CD 
experiment.  
 
3.3. Telomerase activity was suppressed by alkaloids to various extents 
Quantitative telomere-repeat amplification protocol (qTRAP) measurements assessed IC50 levels 
of each compound in samples containing equal amounts of total protein (Figure 4).  A dose-
dependent inhibitory effect was seen in MCF-7 cells treated with the alkaloids. The concentration 
of the alkaloid that leads to 50% telomerase inhibition in MCF-7 cells after 48 hours incubation, 
its IC50, was estimated as 27, 1.25, 1, 1.25 and 60 µM for berberine, chelerythrine, chelidonine, 
sanguinarine and papaverine respectively. In the treated cells berberine at LD50 concentration 
(estimated using MTT assay) suppressed telomerase activity down to 10% of untreated cells. The 
LD50 concentration of chelerythrine showed 60% inhibition of telomerase in the qTRAP assay, 
although it was able to inhibit telomerase even at a very low concentration in a dose-dependent 
manner. Telomerase activity was strongly inhibited at very low concentrations of chelidonine or 
sanguinarine and progressed to almost complete inhibition at their respective LD50.  
 
 
3.4. Chelidonine decreased hTERT expression significantly 
All of the studied alkaloids showed a decreasing effect on the relative hTERT mRNA levels in 
treated MCF-7 cells (Figure 4, black lines). Berberine, inhibited hTERT transcription down to 
about 18 ± 5.2% of untreated control cells at 3 µM and with no further decrease up to its LD50 
value of 54 µM. However, chelidonine showed a significant suppression of hTERT transcription. 
The quantitative real-time RT-PCR technique estimated the strongest decrease in mRNA level of 
hTERT in MCF-7 cells 48 h treated with 8 μM      d         3.5 ± 1.5 % of untreated controls. A 
reduction of hTERT mRNA level to ~60% and less than 40% of untreated cells was observed 
when the cells were treated with 0.1 and 1 µM of chelidonine, respectively (Figure 4). 
Chelerythrine and sanguinarine reduced hTERT transcription to 35 ± 3.2% and 32 ± 3.3% of 
untreated controls at their respective IC50 values.  
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3.5. Chelerythrine showed the strongest interaction with G4 structure  
Thermal FRET analysis of the double-labeled oligonucleotide F21T showed different Tm for G4-
alkaloid complexes, indicating that the complexes tested here had different stabilities (Figures 5 
and 6B). The Tm values of F21T in 100 mM sodium cacodylate buffer containing 100 mM KCl 
were calculated at 73°C using dF/dT curves by Rotor-Gene 6.01 software.  
 
The significant high Tm measured for F21T in presence of Chelerythrine and Sanguinarine 
indicated a strong binding with telomeric G4 structures. Chelerythrine showed the strongest 
interaction with F21T; as it increased the melting temperature by ~6 °C at equal concentration of 
F21T and chelerythrine (Figures 5A and 6B green line). Sanguinarine also showed strong binding 
to F21T, although it was weaker than chelerythrine (Figure 5A and 6B orange line). T   ΔTm 
caused by sanguinarine on F21T was about 3°C at equimolar concentration. However, berberine, 
cheldionine and papaverine did not increase the melting temperature of F21T at 1:1 concentration 
ratio (Figures 5A and 6B; the dark blue, red and blue curves respectively). This suggests a very 
weak interaction between these alkaloids and F21T. The interaction of the ligands with the 
unlabeled telo-21G and its stabilization as monitored by CD290 nm melting shows a similar overall 
pattern from strong binding to weaker interactions (Figure 6A; the same colors as 5A and 6B). 
Aga         y          w           g         a         d    g a ΔTm of 18°C at 100/1 with 
berberine second at 12°C, both cheldionine and papaverine were the weakest.  
 
3.5.1. G4-duplex transition in the presence of ligands  
The specificity of interactions of alkaloids with G-rich F21T oligonucleotide was verified by 
performing G4-duplex transition experiments in the presence of the complementary 
oligonucleotide CT22 using a modified thermal FRET method. In these experiments, equimolar 
solutions of both, F21T and CT22, were first boiled at 95°C for 10 min followed by immediate 
chilling on ice. Incubating the mixture of oligonucleotides at 37°C allows folding of either duplex 
or quadruplex structures. A duplex structure will be preferred in the absence of a quadruplex 
stabilizing ligand. Formation of the folded structure in G-rich strand will be detectable by lower 
fluorescence intensity than control at the beginning of heating step in FRET measurements. In the 
absence of any alkaloid, an equimolar mixture of F21T and CT22 showed a sigmoidal curve 
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14 
starting with high fluorescence intensity at the beginning of FRET measurements (because of 
flurophore dye separation by duplex formation) followed by a clear transition step, ma   d a  “a” 
(Figure 5A, middle), that correlated with melting temperature of the double helix structure. 
However, when the strands are separated (at least a fraction of) the G-rich strand F21T 
oligonucleotid   a     d      G4           (d     d a  “GQ” in the curve). By continued heating, a 
second transition step occurs by denaturing the quadruplexes and if any suitable ligand stabilizes 
     G4            a ∆Tm will be observed, ma   d a  “b”        curve (Figure 5B, middle). 
 
Folding of F21T in the presence of any ligand will lead to fluorescence quenching. On the other 
hand, if the ligand strongly interacts with the duplex and stabilizes it, no such quenching will occur 
and probably a positive ∆Tm is recorded      a             “a”. Meanwhile the ligands that interact 
with G4 structure may quench fluorescence leading to lower fluorescence intensity, G4 formation 
   F21T a    w     m   a     a d a   ga     ∆Tm      a             “a”. This modified FRET-
melting method may help to differentiate between quadruplex and duplex specific ligand binding. 
None of the alkaloids in this study stabilized F21T:CT22 duplex, however chelerythrine and 
sanguinarine exhibited strong fluorescence quenching at the beginning of the heating and a 
  ga     ∆Tm          a             “a” (Figure 5A, middle). While other ligands made no changes 
on both transition steps. Chelerythrine and in a lesser amount sanguinarine increased Tm of F21T 
as observed in   a             “ ”. This suggests the stronger effects of these two 
benzophenanthridine alkaloids on telomeric G4 stabilization. 
 
Chelidonine did not show any considerable changes in melting temperature of F21T, in presence 
or absence of CT22, although it has previously been shown to inhibit telomerase [12]. 
Chelerythrine and sanguinarine exhibited a significant stabilization effect on telomeric G4 
structure even in the presence of the complementary strand, CT22. In the presence of equimolar 
concentration of these alkaloids, the fluorescence intensity of F21T largely decreased at the 
beginning of the heating step of the FRET measurements. The lower fluorescence intensity 
reasonably correlated with the folded state of F21T quadruplex. Both chelerythrine and 
sanguinarine strongly favored F21T folding into G4 than hybridizing with CT22 to a duplex DNA. 
The lowest fluorescence intensity of F21T was detected in the presence of equimolar concentration 
of chelerythrine and sanguinarine which caused a ~50 and 40% decrease in fluorescence intensity 
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15 
respectively. Berberine exhibited a weaker quadruplex stabilizing effect than chelerythrine and 
sanguinarine, while reducing the fluorescence intensity of F21T by about 30%. Papaverine and 
cheldionine did not show any   g     a   ΔTm in F21T similar to the classic FRET-melting 
experiments. 
 
The second transition step “ ” was almost the same as observed in classical FRET-melting 
experiments (without the complementary CT22) and the Tm values are almost the same (it was 
highlighted with red rectangle for berberine in Figure 5B). In summary these observations support 
the more selective interaction of chelerythrine than sanguinarine and berberine with telomeric 
sequences. 
 
3.5.2. Molecular dynamics of telomeric-G4 in complex with isoquinolines 
Since no structural data of the studied complexes is available, automated ligand docking and MD 
simulations were carried out to examine the plausible binding features of the ligands with the G4. 
The binding energies in kcal/mol, calculated after docking the ligands to the quadruplex were in 
the following order:  
 
Chelerythrine (-29.5) > Berberine (-25.6) > Sanguinarine (-23.6) > Chelidonine (-19.6) > 
Papaverine (-16.6) 
 
The final configuration of the systems, after 250 ns MD run revealed that the ligands stacked on 
the quartet with the chromophore maximizing the π-π stacking interactions. The nitrogen in the 
ligand molecules exhibited a preference to position on top of central electronegative channel that 
runs through the G4 (Figure 7). The final results from the MD simulations of the complexes are 
presented in the Supplementary data section. 
 
3.6. The alkaloids generally inhibited both telomerase and Taq polymerase 
Ligand-TRAP assay carried out in the presence of chelerythrine, berberine and sanguinarine 
showed that the alkaloids inhibited telomerase by varying degrees (Figure 8). The effect was not 
specific to telomerase as similar effect was observed when the alkaloids were added after telomere 
elongation, in which only the Taq polymerase was active. Thus both telomerase and Taq 
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polymerase were inhibited by chelerythrine, sanguinarine and berberine. It suggests that strong 
interaction of these alkaloids with G-rich telomeric sequences, as seen in thermal FRET 
experiments, is most likely by interfering with both telomerase and Taq activity. Telomerase 
inhibition appears after a few rounds of primer extension activity of the enzyme by adding the 
TTAGGG repeats, which adopts G4 structure. The strong interaction of alkaloids may restrict 
access to the substrate. However in presence of chelerythrine, telomerase was more inhibited than 
taq polymerase, as incubation with chelerythrine before substrate extension by telomerase showed 
less TRAP products than incubation after that (Figure 8). No significant reduction in activity of 
telomerase and/or Taq polymerase was observed in our ligand-TRAP experiments when incubated 
with chelidonine (data not shown).  
 
4. Discussion 
Discovery of new drugs that are selectively cytotoxic against cancer cells is one of the primary 
objectives for effective cancer treatment. Natural alkaloids of Chelidonium majus, have been 
reported to induce various cell death mechanisms especially through apoptosis induction [15]. The 
most important benzylisoquinolines in this plant include chelidonine, sangunarine, chelerythrine, 
and berberine with slightly different structures and various extents of anti-proliferative effects in 
cancer cell lines [51-54]. However, more investigation is required to elucidate the detailed 
mechanisms and structure-function relationship relevant to their antiproliferative effects.  
 
This study has focused on a comparative study of selective binding to G4 DNA and anti-
telomerase activity of the main alkaloids of C. majus. MTT experiments revealed that all the 
compounds were cytotoxic in MCF-7 cells. Chelerythrine and sanguinarine were the most 
cytotoxic alkaloids, while chelidonine having a hydroxyl group exhibited a relatively less 
cytotoxicity. Papaverine, a benzyl-isoquinoline alkaloid with fewer aromatic rings in its structure 
and more flexible than berberine, has shown least cytotoxicity (LD50 about 120 µM estimated 
using MTT). Papaverine also has inhibitory effects on telomerase activity and hTERT expression 
in both MCF-7 [48] and HepG2 [49]. 
 
Detection of telomerase activity using a Quantitative TRAP assay revealed a very low-level of 
telomerase activity in MCF-7 cells treated with chelidonine or sanguinarine. As this assay 
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measured the enzyme activity in equal amounts of total protein in samples, the reduced activity 
implies depletion of the relative amount of the active ribonucleoprotein. Telomerase regulation 
albeit very complicated, is mainly through transcriptional regulation of the catalytic subunit of the 
enzyme [53]. In the treated MCF-7 cells with chelidonine and sanguinarine, hTERT mRNA levels 
followed the same diminution as the telomerase activity. Sub-micromolar concentrations of both 
chelidonine and sanguinarine led to a significant decrease in telomerase activity along with a 
decrease in hTERT transcription level. Chelerythrine inhibited telomerase by most extent to ~57% 
of un-treated control cells at its LD50 (2.5 µM). Remarkably, berberine showed a significant 
decrease in telomerase activity to ~16% of untreated cells at 3 µM concentration. It is noteworthy 
that, in spite of berberine, which is a potent genotoxin and strong DNA intercalator [54-56], no 
genotoxicity and hepatotoxicity of chelerythrine and sanguinarine has been suggested in animal 
model up to 5 mg per 1 kg body weight [2, 57].  
 
Another possible mechanism of telomerase inhibition by small molecules is substrate sequestering 
through G4 stabilization [58, 59]. Our thermal FRET analysis suggests chelerythrine exhibited 
greatest affinity and specificity among the studied benzophenantridines towards telomeric G4 
DNA (Figure 5). It interacted strongly with the synthetic substrate of telomerase and stabilized the 
folded G4 structure making it inaccessible to the enzyme. G4 structure stabilization was recorded 
for sanguinarine in a considerably stronger extent than berberine. The ∆Tm of F21T varied 
considerably in presence of these three alkaloids, although molecular modeling methods suggest 
almost the similar mode of interactions and comparable binding energies in the hybrid 3+1 
topology [64]. Non-electrostatic interactions in the binding of small molecules to G4 are preferable 
for telomerase inhibition under physiological conditions [60]. Amongst the alkaloids tested here, 
chelidonine is estimated to have less non-electrostatic interactions than the others as it has an extra 
hydroxyl group and lesser number of aromatic rings. As thermal FRET analysis did not detect any 
considerable increase in melting temperature of F21T in presence of chelidonine, direct 
interference with the telomerase activity by substrate sequestration may not contribute to the 
inhibition mechanism. In our ligand-TRAP analysis also, no significant change in telomerase 
and/or Taq polymerase activity was seen after various incubation times with chelidonine. This is 
consistent with other reports indicating only a minor DNA binding capacity for chelidonine [51]. 
In conclusion, chelidonine does not interact with telomerase (after ligand-TRAP data) nor does it 
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sequester its substrate (after thermal FRET data), but strongly inhibited telomerase mainly through 
hTERT suppression (after qPCR measurments of the hTERT mRNA). Similarly and in agreement 
with our previous reports [28, 49], papaverine also showed no significant interaction with 
telomeric quadruplex.  
 
CD experiments confirm the hybrid 3+1 topology of the G4 structures in presence of the studied 
alkaloids. The ligands showed no considerable changes to enhance the 260 nm peak, while 
reduced the negative peak at 234 nm. This implies almost a similar mode of interaction of the 
ligands with F21T and the unlabeled telo-21G.  
 
In conclusion, chelerythrine, sanguinarine and berberine, interfered with telomerase activity by 
limiting substrate accessibility; while down-regulation of the hTERT gene may also have an 
important contribution [61]. It is known that several G-rich regions exist in promoter of hTERT 
[62]. Whether the latter effect is a consequence of G4 interaction with these isoquinolines requires 
further investigation. These regions are expected to be additional targets for G4 formation in the 
presence of chelerythrine, sanguinarine and berberine.  
 
Based on thermal FRET observations, the number of fused aromatic rings of the ligands may have 
the highest impact on the strength of interaction with telomeric quadruplex. So that by reducing 
the number of the aromatic rings or separating them a smaller ∆Tm will be expected. Inclusion of 
polar substitutions may decrease the interaction. The benzophenanthridine alkaloids have stronger 
interaction with telomeric G4 structure than other isoquinolines. Also, opening the methylene 
dioxy rings may enhance the interactions. This highlights the priority of aromatic and hydrophobic 
interactions in binding of these ligands to telomeric G-quadruplex. 
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Figure Legends 
Figure 1: Chemical structures of berberine, chelidonine, chelerythrine, sanguinarine, and 
papaverine. 
Figure 2: Cell viability of MCF7 cells after 24 (light gray), 48 (gray) and 72 (black) hours 
treatment with different concentrations of berberine, chelerythrine, chelidonine and sanguinarine 
as estimated by MTT. Mean values ± standard error of means is shown. 
 
Figure 3: CD spectra of telo-21G a  1 μM         a        10 mM sodium cacodylate buffer and 
100 mM KCl pH 7.2 alone (purple) and in the presence of an increasing ligand concentration of 
chelerythrine, sanguinarine, berberine, chelidonine and papaverine represented by green, black, 
red, blue, yellow curves respectively at ratios 1:1 (A), 10:1 (B), 100:1 (C) (ligand/ telo-21G. (D) 
Chelerythrine in the presence of telo-21G a  0.25 a d 0.5 μM  (2:1  4:1)      g   g      a d da   
green lines respectively. 
 
Figure 4: Telomerase activity (grey line) and hTERT mRNA level (black line) estimated using q-
TRAP and real-time PCR in MCF-7 cells after 48h treatment with the alkaloids. The mean value ± 
SEM of four logical repeats, each including at least three samples for different concentrations has 
been presented. 
 
Figure 5A: Top: Classical thermal FRET analysis of F21T in 10mM sodium cacodylate, pH 7.2 
and 100 mM K+ alone (black) or equimolar concentration of Berberine (dark blue), Chelidonine 
(red), Chelerythrine (green), Papaverine (blue) and Sanguinarine (orange). Middle: t-FRET 
melting measurements of F21T in the same buffer mentioned above and presence of equimolar 
concerntation of the complementary oligonucleotide CT22. Its shows two tandem sigmoid curves 
starting with high fluorescence intensity at the beginning of FRET measurements where 
F21T:CT22 may form double stranded duplex DNA followed by a clear transition step, marked as 
“a”. By      a   g   m   a  re F21T will be released and may fold into G4 structure (GQ). By 
continuing heating, a second transition step occurs due to denaturation of the quadruplexes, 
ma   d a  “ ”            G-rich strand is also completely unfolded. Bottom: tFRET melting 
measurements of F21T in 10mM sodium cacodylate, pH 7.2 and 100 mM KCl in presence of 
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equimolar concentration of the complementary oligonucleotide CT22 and 1:1 concentration ratio 
of alkaloids as above. Note the similar pattern of this second sigmoidal (boxed rectangle) with the 
classic FRET melting curve illustrated above.  
Figure 5B: (Left) Classical FRET melting of 0.25 μM F21T (  a  )    10mM sodium cacodylate, 
pH 7.2 and 100 mM KCl alone (blue) or in presence of 1:1 (red) , 10:1 (green) and 100:1 (purple) 
ratios of berberine, chelerythrine, chelidonine, papaverine and sanguinarine. (Middle) Transition 
FRET (tFRET) m     g a a y        q  m  a          a        F21T a d  T22 (0.25 μM  a  )    
10 mM and 100mM sodium cacodylate without any alkaloid (black) or in presence of 1:1 (red) , 
10:1 (green) and 100:1 (violet) ratios of berberine, chelerythrine, chelidonine, papaverine and 
sanguinarine. (Right) Classical thermal CD290 nm melt analysis of telo-21G a  1 μM    10 mM 
sodium ca  dy a   a d 100 mM                       a          a         0  1  10  a d 100 μM 
ligands (0:1, 1:1,10:1, 100:1 ligand/ telo-21G) in blue, red, green, purple lines respectively.   
 
Figure 6: (A) The difference in T1/2 of telo-21G in CD290 nm melting test and (B) F21T in classical 
FRET melting in sodium cacodylate buffer, pH 7.2 and 100 mM KCl and in presence of increasing 
concentrations of alkaloids.  
 
Figure 7: Conformations of the alkaloids when bound to 3+1 hybrid topology G4 DNA [64]. The 
central nitrogen in Chelerythrine (green), berberine (yellow), chelidonine (black), sanguinarine 
(red) and papaverine (blue) orients on top of the electronegative channel in the quadruplex 
structure. The side view of how all ligands bind is illustrated in the bottom right corner. 
 
Figure 8: Ligand-TRAP measurements. A master mix of q-TRAP reaction including MCF-7 cell 
lysate was prepared and aliquoted to two sets on ice. Various concentrations of the desired alkaloid 
berberine, chelerythrine and sanguinarine were added as explained in part 2.3. Treatments in 1, 3 
and 5 have been done before primer elongation by telomerase and in 2, 4 and 6 before q-PCR. In 
samples 1, 3 and 5 both telomerase and hot-start Taq polymerase have been exposed to the 
alkaloids while in samples 2, 4 and 6 only hot-start Taq enzyme has been exposed to the alkaloids. 
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Supplementary Section 
Quantitative Telomere Repeat Amplification Protocol (q-TRAP) 
Briefly, a master mix of q-TRAP reaction including MCF-7 cell lysate was prepared and 
aliquoted to two sets on ice (A and B). Various concentrations of the desired alkaloid were added 
to samples of set A and incubated for 30 minutes on ice. Then all samples of both sets were 
incubated for 20 minutes at 24°C for extending TS primer by telomerase. All the samples were 
put back on ice and the same concentrations of alkaloid as set A was added to the samples of set 
B. Only Taq polymerase may be affected in this set. The amplification and quantification were 
done as described in the previous section. This experiment has been repeated at least three times, 
and each repeat included triplicate samples for each concentration of the alkaloid. Traces of 
RNase contamination that potentially can give rise to false positive results was checked by 
incubating total RNA with aliquots of the alkaloids for 0 or 30 minutes at room temperature 
followed by electrophoresis in agarose gel.
Supplementary Material (for online publication)
Click here to download Supplementary Material (for online publication): Supplementary.docx
 Table 1. Time table of incubations and treatments in various sets of ligand TRAP test. 
 
 
  
Time from 
start point 
(min) 
0 30-50 50 50-150 
Set Incubation on ice Telomerase 
activity at 
24°C 
Incubation on 
ice 
Amplification of 
telomerase 
products 
(q-PCR) 
A Treatment with the 
alkaloid 
 -  
B - Treatment with 
the alkaloid 
Molecular Dynamics Simulations 
The ligands studied here display a common mode of binding. The rings of the ligands are able to 
interact via π-π stacking at the exposed surface of the quadruplex.  
Chelerythrine: In the starting structure, the rings of the ligand stack with the G13 and G21 of 
the quadruplex and the nitrogen of the ring align along the cation channel of the quadruplex. 
During the simulation the ligand stacks on half of the quartet, aligning the nitrogen along the 
central axis of the quadruplex. 
Berberine: The ligand has a large surface area and stacks with G13 and G21 from the top 
quartets. The central nitrogen atom in the ring of ligand is aligned along the channel cavity of the 
quadruplex and anchors the ligand. The π-π stacking between the ligand-quadruplex is stable 
throughout the simulation, with the ligand moving around the anchor. 
Sanguinarine:  The rings of the ligand stack with the quartets such that the nitrogen is 
positioned over the central electronegative channel. During the course of the simulation the 
ligand is able to stack above G13 and G21 of the quartet. 
Chelidonine:  In the quadruplex-chelidonine structure, the aromatic rings stacks on one half of 
the top quartet. During the simulation, the ligand shifts to stack with G13 and G21 bases similar 
to the orientation of Chelerythrine. 
Papaverine:  During the simulation, ligand is oriented in such a way that the isoquinoline rings 
stack partially on the top quartet. The nitrogen in the isoquinoline ring is positioned on the 
central channel. The flexiblity around the central methyl linker permits partial stacking of the 
phenyl ring on G21 of the top quartet.  
 
 
 
 
 
